Meta description: Sensus Healthcare, Inc. (NASDAQ: SRTS) experiences a slight drop in stock price, reflecting investor sentiment and market conditions in the medical devices sector.
In this article:
- Company Overview
- Stock Performance
- Market Position and Sector
- Governance and Leadership
- Key Financial Data
- FAQ
- Conclusion
- Disclaimer
- Announcement
Company Overview
Sensus Healthcare, Inc., founded in 2010 and headquartered in Boca Raton, Florida, specializes in manufacturing and selling radiation therapy devices to healthcare providers globally. The company’s product line is built on superficial radiation therapy (SRT), a low-energy X-ray technology. Its devices, such as the SRT-100, SRT-100 Vision, and SRT-100 Plus, offer non-invasive treatment alternatives for non-melanoma skin cancers, keloids, and other conditions. Ancillary services include the Sentinel service program, in-office laser rental services, and a range of disposable radiation safety products.
By targeting specific niches within radiation therapy, Sensus Healthcare has created a focused medical device offering aimed at enhancing patient care while providing physicians with advanced treatment tools.
Stock Performance
On the NASDAQ Capital Market under the symbol SRTS, Sensus Healthcare’s stock is currently priced at USD 3.40. The price has declined by USD 0.05, representing a percentage change of -1.44928%. This modest decrease may reflect short-term market sentiment rather than a fundamental shift in the company’s position. Over the past year, the stock has traded between USD 3.03 and USD 9.329, indicating significant volatility.
Trading volume for the latest session was 64,552 shares, well below its average volume of 138,812 shares. Such a discrepancy may point to reduced investor activity or temporary market disengagement. Investors often examine average trading volumes as an indicator of liquidity and market interest.
Market Position and Sector
Sensus Healthcare operates in the Medical Devices industry within the broader Healthcare sector. This sector is known for consistent demand driven by both technological innovation and demographic trends. Companies in medical devices rely on regulatory compliance, intellectual property protection, and ongoing product development to secure their markets and maintain competitive advantage.
The market capitalization of Sensus Healthcare stands at USD 55,896,000, placing it in the micro-cap category. Micro-cap companies often offer higher potential growth but come with increased risk due to smaller scale and market exposure.
Governance and Leadership
The company is led by CEO Joseph C. Sardano, who plays a central role in guiding strategy, regulatory engagement, and product innovation. With 54 full-time employees, Sensus Healthcare maintains a lean operational structure. Effective leadership in such a setting often requires combining technical understanding with experience navigating complex healthcare markets.
Corporate governance practices, leadership vision, and management competence directly influence investor confidence. While financial indicators are critical, leadership credibility often shapes long-term market valuation.
Key Financial Data
Price: USD 3.40
Market Cap: USD 55.896 million
Last Dividend: None reported
52-week Range: USD 3.03 – USD 9.329
Change: -USD 0.05 (-1.44928%)
Volume: 64,552 shares
Average Volume: 138,812 shares
Dividend information is critical for income-focused investors. Sensus Healthcare has not issued dividends, which suggests reinvestment of profit into operations or growth initiatives rather than direct shareholder payouts. Range data helps assess volatility, and volume figures offer insights into current investor engagement.
Trading Details
- Exchange: NASDAQ Capital Market
- ISIN: US81728J1097
- CUSIP: 81728J109
- CIK: 0001494891
- IPO Date: July 26, 2016
These identifiers provide clarity for regulators, analysts, and institutional investors. They ensure accurate tracking for compliance and reporting purposes.
FAQ
- Does Sensus Healthcare pay dividends? No, the company currently does not pay dividends.
- Where is Sensus Healthcare listed? On the NASDAQ Capital Market under the ticker SRTS.
- What is the number of employees? The company employs 54 full-time staff.
- What is the sector classification? Healthcare sector, Medical Devices industry.
- Who is the CEO? Joseph C. Sardano.
Conclusion
Sensus Healthcare’s current share price movement reflects market caution amid lower-than-average trading volumes. The company’s focused product line and leadership structure position it for targeted growth within the medical devices subsector. Investors should assess the company’s financial fundamentals, market positioning, and product pipeline in the context of industry trends.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult a licensed professional before making investment decisions.
Announcement
For full information about the company, see the link below.